SIAE M89V - GET-Evidence


(See the latest version)


(SIAE Met89Val)

You are viewing an old version of this page that was saved on November 17, 2010 at 11:02am by Madeleine Ball.

Edited in this revision:

Short summary

This variant, which has a 3.4% allele frequency in 1000 genomes data, is reported to be associated with autoimmune disease when homozygous. The statistical significance of the findings is unclear. Assuming it is pathogenic, we estimate that the relative risk of autoimmune disease in homozygous individuals is around 4x (8% risk vs. an average of 2% risk).

Variant evidence
Computational 2

Polyphen predicts “possibly damaging”. Surolia et al. find other variants in this gene associated with autoimmune disease.

See Surolia I et al. 2010 (20555325).

Functional 2

Protein product with this variant is catalytically active but is not secreted. This finding was reproduced in a pulse-chase experiment with 35S-methionine.

See Surolia I et al. 2010 (20555325).

Case/Control 1

p = 0.024, but multiple hypotheses were tested (other variants in the same gene)

See Surolia I et al. 2010 (20555325).

Familial -
Clinical importance
Severity 3

Autoimmune diseases have a wide range of effects.

Treatability 4

Can be treated with immunosuppressive drugs.

Penetrance 3

~6% attributable increased risk

See Surolia I et al. 2010 (20555325).



Moderate clinical importance, Uncertain pathogenic

(The "moderate clinical importance, uncertain" qualifier is assigned automatically based on the above evidence and importance scores.)

Inheritance pattern


Summary of published research, and additional commentary

Surolia, I. et al. Nature advance online publication doi:10.1038/nature09115 (2010). — This paper implicates this polymorphism as potentially contributing to autoimmune diseases when homozygous. The variant was seen homozygously in 8 out of 923 cases and 0 out of 648 controls. Using two-tailed Fisher’s Exact, this is p = 0.024. However, because there are several other polymorphisms, multiple hypotheses were implicitly being tested and so we give this a case/control significance of 1 point (0.1 < p < 0.05). The overall allele frequency of the variant in controls is 0.049, they list four other variants with allele frequencies > 0.025.

They report that the protein product with this variant is catalytically active but is not secreted. This finding was reproduced in a pulse-chase experiment with 35S-methionine.

This data suggests homozygosity for this variant explains ~1% of autoimmune cases. An allele frequency of 0.049 implies that .24% of people are homozygous for this variant. Assuming an incidence of autoimmune disease in 1 out of 50 people, 0.02% of people would be expected to have autoimmune disease that might be attributed to this variant — this puts an estimate of penetrance for autoimmune disease in the homozygous individuals at ~8% (.02 / .24), approximately fourfold relative risk.

Allele frequency

  • C @ chr11:124530664: 4.0% (431/10758) in EVS
  • C @ chr11:124035873: 5.5% (7/128) in GET-Evidence
  • Frequency shown in summary reports: 4.0% (431/10758)


Surolia I, Pirnie SP, Chellappa V, Taylor KN, Cariappa A, Moya J, Liu H, Bell DW, Driscoll DR, Diederichs S, Haider K, Netravali I, Le S, Elia R, Dow E, Lee A, Freudenberg J, De Jager PL, Chretien Y, Varki A, Macdonald ME, Gillis T, Behrens TW, Bloch D, Collier D, Korzenik J, Podolsky DK, Hafler D, Murali M, Sands B, Stone JH, Gregersen PK, Pillai S. Functionally defective germline variants of sialic acid acetylesterase in autoimmunity. Nature. 2010 Jul 8;466(7303):243-7. Epub 2010 Jun 16. PubMed PMID: 20555325; PubMed Central PMCID: PMC2900412.



hu43860C - CGI sample GS00253-DNA_A01_200_37
het C @ chr11:124530664


hu9385BA - CGI sample GS00253-DNA_E01_200_37
het C @ chr11:124530664


Other external references

  • rs78778622
  • Score: 0.015 (benign)

Other in silico analyses

  • NBLOSUM100 score = 0
  • GET-Evidence autoscore = 0

Edit history

Gene search

"GENE" or "GENE A123C":

Log in